Search

everythinglearnresearchcommunity

for

Search:↓

Removing myelin protein zero-like 3 in mice leads to better metabolism and resistance to obesity.

Understanding and manipulating epigenetic changes can potentially lead to human organ regeneration therapies, but more research is needed to improve these methods and minimize risks.

Terbinafine can cause hair loss.

A specific enzyme is essential for proper hair follicle stem cell development and healthy skin.

A rare skin condition was confirmed to be associated with a specific virus in a young girl.

Platelet factor 4 slows down hair growth and could make hair loss treatments more effective if removed.

The vitamin D receptor helps regulate skin and hair health independently of its usual vitamin D ligand.

Hair follicle stem cells change states with age, affecting hair growth and aging.

DNMT1 helps turn hair follicle stem cells into fat cells by blocking a specific microRNA.

A specific genetic change in the KRT71 gene causes a hair loss condition in Hereford cattle.

The study identified unique genes in hair follicle cells and their environment, suggesting these genes help organize cells for hair growth.

The enzymes Tet2 and Tet3 are important for skin cell development and hair growth.

Epigenetic mechanisms control skin development by regulating gene expression.

CCCA is a common, progressive hair loss condition that may not always be linked to hair care practices and requires a biopsy for diagnosis.

Longer hair loss leads to more severe CCCA; early treatment and avoiding damaging hairstyles help regrowth.

Topical metformin helped regrow hair in two women with a hard-to-treat scarring hair loss condition.

CCCA is a common hair loss condition in African American women, often inherited and influenced by hairstyling, with unique scalp features detectable by special tools.

Some people with pattern hair loss may also have scalp inflammation and scarring similar to lichen planopilaris.

Women's hair loss can be due to hormonal changes and various conditions, with treatments focusing on stopping progression and managing symptoms.

Effective treatment for midlife women's hair loss is limited, with 5% minoxidil foam being the only proven option for the most common type.

CCCA is a scarring hair loss condition mainly in African descent women, possibly caused by genetics and hairstyling, treated with gentle hair care and medications.

CCCA is a scarring hair disorder mainly affecting people of African descent, needing better awareness and treatment.

Elderly patients with CCCA were all African American with low vitamin D, but no iron or zinc deficiencies, and no hormonal imbalances compared to younger patients.

Seborrhoeic dermatitis may cause a condition called "seborrhoeic folliculitis," leading to chronic scalp inflammation and scarring hair loss.

The report found a new type of hair loss in African-American women that affects more areas of the scalp than previously thought.

Some hair loss disorders cause permanent loss due to scarring, and treatments like steroids don't always work well.

Early diagnosis and aggressive treatment are key for managing rare scalp disorders that cause permanent hair loss.

The document concludes that more research is needed to better understand and treat scarring hair loss conditions.

The document concludes that alopecia has various forms, each with specific treatments, but no definitive cure for certain types like CCCA has been proven.

Altered retinoid metabolism in cicatricial alopecia suggests a balanced vitamin A diet may prevent the condition.